These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37277227)

  • 21. Determine the impact of a structured pharmacist-led medication review - a controlled intervention study to optimise medication safety for residents in long-term care facilities.
    Lexow M; Wernecke K; Sultzer R; Bertsche T; Schiek S
    BMC Geriatr; 2022 Apr; 22(1):307. PubMed ID: 35397527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
    Haga SB; Moaddeb J; Mills R; Voora D
    Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic Testing in Depressed Patients and Interdisciplinary Exchange between a Pharmacist and Psychiatrists Results in Reduced Hospitalization Times.
    Bättig VAD; Roll SC; Hahn M
    Pharmacopsychiatry; 2020 Jul; 53(4):185-192. PubMed ID: 32045941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.
    O'Connor SK; Ferreri SP; Michaels NM; Greco AJ; Viera AJ; Faruki H; McLeod HL; Roederer MW
    Pharmacogenomics; 2012 Jun; 13(8):955-62. PubMed ID: 22676199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?
    Solomon HV; Cates KW; Li KJ
    Psychiatry Res; 2019 Jan; 271():604-613. PubMed ID: 30554109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist and physician perception of pharmacogenetic testing.
    Bruno Xuereb AM; Wirth F; Mifsud Buhagiar L; Camilleri L; Azzopardi LM; Serracino-Inglott A
    Int J Pharm Pract; 2022 May; 30(2):188-191. PubMed ID: 35225344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods.
    Zhai XB; Tian DD; Liu XY
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.
    Finkelstein J; Friedman C; Hripcsak G; Cabrera M
    Pharmgenomics Pers Med; 2016; 9():107-116. PubMed ID: 27789970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of medication reconciliation at hospital admission on medication discrepancies during hospitalization and at discharge for geriatric patients.
    Cornu P; Steurbaut S; Leysen T; De Baere E; Ligneel C; Mets T; Dupont AG
    Ann Pharmacother; 2012 Apr; 46(4):484-94. PubMed ID: 22414793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
    Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
    J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
    Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
    Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
    Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
    Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacist-led program on medication reconciliation implementation at hospital admission: experience of a single university hospital in Croatia.
    Marinović I; Marušić S; Mucalo I; Mesarić J; Bačić Vrca V
    Croat Med J; 2016 Dec; 57(6):572-581. PubMed ID: 28051282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.
    Elliott LS; Henderson JC; Neradilek MB; Moyer NA; Ashcraft KC; Thirumaran RK
    PLoS One; 2017; 12(2):e0170905. PubMed ID: 28151991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.